Business Daily Media

Business Marketing

.

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body Cancer in Japan

  • Written by ACN Newswire - Press Releases

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body Cancer in Japan

TOKYO, Apr 23, 2021 - (JCN Newswire) - Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside the United States and Canada) announced today an application submission in Japan for the additional indication of Eisai's in-house discovered and developed multiple receptor tyrosine kinase

Read more //?#

Popular

Need to ask your boss for menopause leave? Here are 5 tips directly from an expert

The stage of life called menopause is when a woman’s reproductive hormone production begins to change, marking a significant new milestone in our lives. The beginning of menopause, otherwise known as perimenopause, typically o...

One taxi driver’s big plans to flip the multimillion dollar rideshare industry on its head in 2021

Keith Logan and Delsie Cook are the Perth based entrepreneurs behind the much-anticipated launch of MooVr – Australia’s answer to affordable, fair ridesharing.  “After several years as a taxi driver, as well as someone wh...

Expert guide for foolproof sales shopping

Paul offers his foolproof tips for Aussies shopping this Click Frenzy Mayhem:   Plan ahead to avoid impulse purchases and returns. It can be tempting to snap up every bargain when shopping during the 53-hour Click Frenzy ...